KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Dividends payables: 2009-2010

Historic Dividends payables for Bausch Health Companies (BHC) over the last 2 years, with Sep 2010 value amounting to $15.1 million.

  • Bausch Health Companies' Dividends payables rose 5.88% to $15.1 million in Q3 2010 from the same period last year, while for Sep 2010 it was $15.1 million, marking a year-over-year increase of 5.88%. This contributed to the annual value of $14.2 million for FY2009, which is N/A change from last year.
  • Per Bausch Health Companies' latest filing, its Dividends payables stood at $15.1 million for Q3 2010, which was up 5.77% from $14.3 million recorded in Q2 2010.
  • Bausch Health Companies' 5-year Dividends payables high stood at $59.3 million for Q1 2009, and its period low was $14.2 million during Q3 2009.
  • Moreover, its 2-year median value for Dividends payables was $14.3 million (2010), whereas its average is $27.2 million.
  • The largest annual percentage gain for Bausch Health Companies' Dividends payables in the last 5 years was 5.88% (2010), contrasted with its biggest fall of 75.97% (2010).
  • Quarterly analysis of 2 years shows Bausch Health Companies' Dividends payables stood at $14.2 million in 2009, then grew by 5.88% to $15.1 million in 2010.
  • Its Dividends payables was $15.1 million in Q3 2010, compared to $14.3 million in Q2 2010 and $14.3 million in Q1 2010.